key: cord-0903347-hxmoscch
authors: Corpuz, Jeff Clyde G
title: Building vaccine confidence through public participation
date: 2021-05-21
journal: J Public Health (Oxf)
DOI: 10.1093/pubmed/fdab171
sha: 49afc0dce08192de883e22830e37a0ac117b9e27
doc_id: 903347
cord_uid: hxmoscch

A recently published correspondence proposed the involvement of private-owned companies in Coronavirus Disease 2019 (COVID-19) vaccination program. This article raises awareness that vaccine hesitancy could undermine the effectiveness of COVID-19 vaccination programs. This article proposes the idea of public participation: dialog-based approach, incentive-based (non-financial) approach and reminder-recall approach based on the World Health Organization guidelines.

The author of this article would like to thank Vicente and Cordero for their correspondence regarding my paper on Multisectoral Approach (MSA) to Coronavirus Disease 2019 (COVID-19) vaccination program. 1 This approach involves the participation and collaboration of various stakeholders to achieve quality outcomes. Vicente and Cordero stated that 'one important sector that is vital in the government's vaccination program is the private-owned companies'. 2 Although they referred to the role private companies in motivating companies to help their employees through Corporate Social Responsibility (CSR), my proposal integrates all major stakeholders (both public and private) to share their most common vision and perspective to build vaccine confidence.

The World Health Organization (WHO) has discussed the behavioral considerations of COVID-19 acceptance and suggested di erent approaches to increasing vaccine acceptance. These include building an enabling environment and using open communication to address people's beliefs and uncertainty, educating them about the safety and e cacy of the vaccine. 3 Social and governmental collaboration will increase public confidence in the COVID-19 vaccine and will enable the country to reach herd immunity rapidly. An Australian study provided a framework that could be used by health care providers to increase confidence in any potential COVID-19 vaccines. They said that 'ensuring public confidence in vaccine safety and e ectiveness will be crucial to facilitate uptake'. 4 Vaccine hesitancy could undermine the e ectiveness of COVID-19 vaccination programs and may be considered as a major barrier for the development of a COVID-19 vaccine in the future and in reaching herd immunity. 5 Attempts to answer the problem of vaccine hesitancy can be found in a wide range of medical guidelines by the WHO documents, many of which embrace the foundational principle of 'save the most lives'. Vaccine confidence is predicated on the idea of public participation: dialog-based approach, incentivebased (non-financial) approach and reminder-recall approach. First, dialog-based approach includes the involvement of religious or traditional leaders, social mobilization, social media, mass media and communication-or informationbased tools for health care workers. Second, incentive-based (non-financial) includes the provision of food or other goods to encourage vaccination. Lastly, reminder-/recall-based approach includes telephone call/letter to remind the target population about vaccination. 6 In conclusion, vaccine hesitancy is a complex issue and no single model will be able to address it. However, there are some promising examples of strategies that will help mitigate the vaccine hesitancy of the public. This could be achieved by designing and implanting di erent awareness campaigns via various media outlets guided by health care providers. Although addressing vaccine hesitancy is important to combat the negative perception of the public, building confidence and public trust are unlikely to be su cient to address the barriers in promoting safe and e ective vaccines. There is a continuing need to also focus on addressing the social, political, legal and ethical issues during and beyond COVID-19 vaccination.

No funding was received for this paper.

Multisectoral approach on COVID-19 vaccination: a proposed solution on vaccine hesitancy

Because we care': private companies to embody the corporate social responsibility for a successful COVID-19 vaccination program in the Philippines

World Health Organization. Behavioural Considerations for Acceptance and Uptake of COVID-19 Vaccines: WHO Technical Advisory Group on Behavioural Insights and Sciences for Health, Meeting Report

Preparing the public for COVID-19 vaccines: how can general practitioners build vaccine confidence and optimise uptake for themselves and their patients?

Planning for a COVID-19 vaccination program

WHO SAGE working group dealing with vaccine hesitancy. Strategies for Addressing Vaccine Hesitancy -A Systematic Review

The author declares no conflict of interest in this paper.